| Qualification Type: | PhD |
|---|---|
| Location: | Birmingham |
| Funding for: | UK Students, EU Students, International Students |
| Funding amount: | Funded by BBSRC |
| Hours: | Full Time |
| Placed On: | 29th October 2025 |
|---|---|
| Closes: | 27th November 2025 |
Cardiometabolic diseases (CVMD), such as heart disease and type 2 diabetes, represent a major global health burden and exhibit stark ethnic disparities. Current clinical prediction models, even those using advanced AI, often fail to capture the nuanced clinical and social factors driving these differences, leading to inequitable health outcomes. This is largely because they struggle to leverage the rich, unstructured information found in clinical notes and cannot effectively gather data on lifestyle and social determinants of health.
This PhD project will pioneer a novel, hybrid AI framework to directly address this critical gap. The research aims to develop a more accurate and equitable tool for early CVMD risk prediction, with a specific focus on the underserved South Asian population, who carry a disproportionately high disease burden.
The project is built on a powerful two-part methodology:
This is a highly interdisciplinary project at the intersection of machine learning, health equity, and precision medicine. The successful candidate will join a vibrant research environment and gain extensive, hands-on experience in:
We are seeking a highly motivated candidate with a strong quantitative background (e.g., in computer science, statistics, bioinformatics). The following skills are essential for this project:
Knowledge of analysing genomic data is highly desirable albeit not essential. This project offers a unique opportunity to develop state-of-the-art AI solutions that can create a tangible impact by reducing health inequalities and improving clinical outcomes for all populations.
This is a PhD studentship with the Midlands Integrated Biosciences Training Partnership, funded by BBSRC.
References:
Rashid et al. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
Jackstadt et al. Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis.
Lo JA et al. Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses.
Walker et al. Hydroxymethylation profile of cell-free DNA is a biomarker for early colorectal cancer.
Kabir et al. Automatic speech recognition for biomedical data in bengali language.
Type / Role:
Subject Area(s):
Location(s):